Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00004038 | Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00030615 | Decitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer |
| completed |
| Phase 1 |
| 40 |
| Dana-Farber Cancer InstituteOTHER |
| 1 |
| Feb 7, 2013 |
| clinicaltrials |
| NCT00055991 | Bexarotene in Preventing Breast Cancer in Women at Genetic Risk | completed | Phase 1 | 87 | Baylor Breast Care CenterOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00028496 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00372424 | Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive | completed | Phase 1 | 26 | PfizerINDUSTRY | 2 | Dec 28, 2012 | clinicaltrials |
| NCT00972413 | Cone Beam Computed Tomography for Breast Imaging(CBCTBI) | completed | Phase 1 | 104 | Koning CorporationINDUSTRY | 1 | Dec 17, 2012 | clinicaltrials |
| NCT00003357 | Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT00128622 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | H. Kim LyerlyOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT01044485 | Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer(LapDoc) | completed | Phase 1 / Phase 2 | 17 | Centre Georges Francois LeclercOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00614978 | Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer(LAPTEM) | completed | Phase 1 | 18 | Jules Bordet InstituteOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00028977 | Herbal Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 21 | University of California, San FranciscoOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT00068757 | Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | completed | Phase 1 | 23 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 12, 2012 | clinicaltrials |
| NCT01041235 | Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies | completed | Phase 1 | 29 | Azaya Therapeutics, Inc.INDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00645541 | Axillary Reverse Mapping for Invasive Carcinoma of the Breast | completed | Phase 1 | 35 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00002837 | High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00008034 | Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer | completed | Phase 1 | 15 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00788333 | Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer | completed | Phase 1 / Phase 2 | 40 | Bristol-Myers SquibbINDUSTRY | 5 | Jul 13, 2012 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00717340 | A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer | completed | Phase 1 | 18 | AVEO Pharmaceuticals, Inc.INDUSTRY | 2 | Jun 28, 2012 | clinicaltrials |
| NCT00749437 | Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer | completed | Phase 1 | 34 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00412412 | CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study | completed | Phase 1 | 34 | BiogenINDUSTRY | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00006225 | Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00162929 | Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)(AdHERe) | completed | Phase 1 | 5 | Ontario Clinical Oncology Group (OCOG)OTHER | 0 | Jun 4, 2012 | clinicaltrials |
| NCT00307229 | Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) | completed | Phase 1 | 8 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00003902 | Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement | completed | Phase 1 / Phase 2 | 110 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00031876 | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 34 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00708903 | Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization) | completed | Phase 1 | 60 | Puma Biotechnology, Inc.INDUSTRY | 1 | May 14, 2012 | clinicaltrials |
| NCT01089049 | Effect of a Natural Health Product on Urinary Estrogen Metabolites | completed | Phase 1 / Phase 2 | 98 | Nutrasource Pharmaceutical and Nutraceutical Services, Inc.NETWORK | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00454532 | A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 27 | BionovoINDUSTRY | 0 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00054977 | Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors | completed | Phase 1 | 40 | Galectin Therapeutics Inc.INDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00064311 | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00432562 | A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. | completed | Phase 1 | 31 | Mast Therapeutics, Inc.INDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00006108 | Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01108315 | Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice | completed | Phase 1 / Phase 2 | 138 | BrightOutcomeINDUSTRY | 1 | Feb 6, 2012 | clinicaltrials |
| NCT01070706 | Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib(PGS) | completed | Phase 1 / Phase 2 | 15 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
| NCT01133912 | Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)(PGT) | completed | Phase 1 | 13 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
| NCT00862901 | Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma(CLIPT) | completed | Phase 1 | 48 | Tufts Medical CenterOTHER | 1 | Sep 26, 2011 | clinicaltrials |
| NCT00661739 | A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer(RiTa) | completed | Phase 1 | 38 | GBG Forschungs GmbHOTHER | 0 | Sep 2, 2011 | clinicaltrials |
| NCT00050167 | Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | completed | Phase 1 | 603 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00916877 | Prophylactic Cranial Irradiation in Patients With HER-2-Positive Metastatic Breast Cancer | completed | Phase 1 | 110 | Alberta Health servicesOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT00003038 | Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00003690 | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00004085 | Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00505271 | Safety and Efficacy Study Using Rexin-G for Breast Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00031278 | Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 12 | PfizerINDUSTRY | 1 | May 30, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Feb 7, 2013source: clinicaltrials